152 related articles for article (PubMed ID: 20105078)
1. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
Iannacone MR; Michael KM; Giuliano AR; Waterboer T; Pawlita M; Rollison DE
J Infect Dis; 2010 Mar; 201(5):760-9. PubMed ID: 20105078
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; Barón AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
[TBL] [Abstract][Full Text] [Related]
3. Review: antibodies to cutaneous human papillomaviruses.
Antonsson A
J Med Virol; 2012 May; 84(5):814-22. PubMed ID: 22431031
[TBL] [Abstract][Full Text] [Related]
4. Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions.
Andersson K; Waterboer T; Kirnbauer R; Slupetzky K; Iftner T; de Villiers EM; Forslund O; Pawlita M; Dillner J
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):189-95. PubMed ID: 18199724
[TBL] [Abstract][Full Text] [Related]
5. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
[TBL] [Abstract][Full Text] [Related]
6. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin.
Waterboer T; Abeni D; Sampogna F; Rother A; Masini C; Sehr P; Michael KM; Pawlita M
Br J Dermatol; 2008 Aug; 159(2):457-9. PubMed ID: 18503604
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.
Karagas MR; Nelson HH; Sehr P; Waterboer T; Stukel TA; Andrew A; Green AC; Bavinck JN; Perry A; Spencer S; Rees JR; Mott LA; Pawlita M
J Natl Cancer Inst; 2006 Mar; 98(6):389-95. PubMed ID: 16537831
[TBL] [Abstract][Full Text] [Related]
8. HPV 6/11, 16, 18 seroprevalence in men in two US cities.
Dunne EF; Nielson CM; Hagensee ME; Papenfuss MR; Harris RB; Herrel N; Gourlie J; Abrahamsen M; Markowitz LE; Giuliano AR
Sex Transm Dis; 2009 Nov; 36(11):671-4. PubMed ID: 19809385
[TBL] [Abstract][Full Text] [Related]
9. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
[TBL] [Abstract][Full Text] [Related]
10. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men.
Lu B; Hagensee ME; Lee JH; Wu Y; Stockwell HG; Nielson CM; Abrahamsen M; Papenfuss M; Harris RB; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):511-6. PubMed ID: 20086109
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
[TBL] [Abstract][Full Text] [Related]
12. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
13. Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program.
Učakar V; Jelen MM; Faust H; Poljak M; Dillner J; Klavs I
Vaccine; 2013 Oct; 31(43):4935-9. PubMed ID: 23994822
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study.
Antonsson A; Green AC; Mallitt KA; O'Rourke PK; Pandeya N; Pawlita M; Waterboer T; Neale RE
Virology; 2010 Nov; 407(1):26-32. PubMed ID: 20723959
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous wart-associated HPV types: prevalence and relation with patient characteristics.
Bruggink SC; de Koning MN; Gussekloo J; Egberts PF; Ter Schegget J; Feltkamp MC; Bavinck JN; Quint WG; Assendelft WJ; Eekhof JA
J Clin Virol; 2012 Nov; 55(3):250-5. PubMed ID: 22884670
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
17. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
[TBL] [Abstract][Full Text] [Related]
18. Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Viscidi RP; Ahdieh-Grant L; Schneider MF; Clayman B; Massad LS; Anastos KM; Burk RD; Minkoff H; Palefsky J; Levine A; Strickler H
J Infect Dis; 2003 Dec; 188(12):1834-44. PubMed ID: 14673762
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence and risk factors for human papillomavirus in Taiwan.
Wang IJ; Viscidi R; Hwang KC; Lin TY; Chen CJ; Huang LM; Chen HH; Chen CJ
J Trop Pediatr; 2008 Feb; 54(1):14-8. PubMed ID: 17984124
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals.
Masini C; Fuchs PG; Gabrielli F; Stark S; Sera F; Ploner M; Melchi CF; Primavera G; Pirchio G; Picconi O; Petasecca P; Cattaruzza MS; Pfister HJ; Abeni D
Arch Dermatol; 2003 Jul; 139(7):890-4. PubMed ID: 12873884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
